Filing Flows › Immunocore Holdings (IMCR) › Free cash flow
Immunocore Holdings (IMCR) free cash flow by quarter
Immunocore Holdings' free cash flow was $17.7M in Q3 2026 (third quarter 2026), +17% from Q2 2026. Over the last 4 quarters it ranged from $137K (Q1 2025) to $25.6M (Q2 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $17.7M | +17% | — |
| Q2 2026 | $15.1M | -41% | -41% |
| Q2 2025 | $25.6M | 186× | — |
| Q1 2025 | $137K | — | — |
Q3 2026 at a glance
Immunocore Holdings, Q3 2026: revenue $102M (-1% year over year), operating margin -13.3%, net loss $14.2M, operating cash flow $20.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Immunocore Holdings' free cash flow?
Immunocore Holdings' free cash flow was $17.7M in Q3 2026 (third quarter 2026), +17% from Q2 2026.
How has Immunocore Holdings' free cash flow changed?
Over the last 4 quarters it ranged from $137K (Q1 2025) to $25.6M (Q2 2025).